Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-5 of 5
Keywords: copper
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2016) 130 (8): 565–574.
Published: 08 March 2016
...Katherine M. Davies; Julian F.B. Mercer; Nicholas Chen; Kay L. Double Copper is a biometal essential for normal brain development and function, thus copper deficiency or excess results in central nervous system disease. Well-characterized disorders of disrupted copper homoeostasis with neuronal...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (1981) 60 (2): 207–212.
Published: 01 February 1981
... hepatic copper there was a small decrease, but urinary copper excretion was unaltered. Hepatic organelle pathology was significantly improved. 3. No serious side-effects were noted and it is suggested that a controlled trial of low-dose D-penicillamine therapy is indicated in patients with primary biliary...
Articles
Journal:
Clinical Science
Clin Sci Mol Med (1977) 53 (4): 317–320.
Published: 01 October 1977
...Kathleen Gibbs; J. M. Walshe 1. A screening procedure is described to assess rapidly the clinical potential of chelating agents for the treatment of Wilson's disease. 2. Rats were used as the test animal; they were kept in metabolic cages and the urine was collected in copper-free containers...
Articles
Journal:
Clinical Science
Clin Sci Mol Med (1976) 51 (4): 369–378.
Published: 01 October 1976
... and peptide-bound amino acid output in cases of Wilson's disease and in control subjects was mainly quantitative; the pattern of amino acid excretion was qualitatively similar in both groups. 4. Evidence is presented that the increased copper output in the urine in the disease is not secondary to peptiduria...
Articles
Journal:
Clinical Science
Clin Sci Mol Med (1973) 44 (1): 9–15.
Published: 01 January 1973
... weight exceeding 50 000. The remaining biliary 64 Cu was in a low-molecular-weight component. 3. Above pH 4, 64 Cu could not readily be removed from the macromolecular complex either by excess carrier copper ions, by d-penicillamine or by EDTA. 4. Absorption of 64 Cu from 64 Cu-labelled bile injected...